Company · Varennes, Quebec, Canada
Nora Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 273
- 219 authorized now
- Natural health products
- 10
- 10 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 201
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| NIOPEG | 02546973 | Marketed | |
| NRA-ALENDRONATE | 02523116 | Marketed | |
| NRA-AMLODIPINE | 02476452 | Marketed | |
| NRA-AMLODIPINE | 02476460 | Marketed | |
| NRA-AMLODIPINE | 02476479 | Marketed | |
| NRA-AMOXICILLIN | 02561417 | Marketed | |
| NRA-APIXABAN | 02526069 | Marketed | |
| NRA-APIXABAN TABLETS | 02546884 | Marketed | |
| NRA-APIXABAN TABLETS | 02546892 | Marketed | |
| NRA-ARIPIPRAZOLE | 02472201 | Marketed | |
| NRA-ARIPIPRAZOLE | 02472228 | Marketed | |
| NRA-ARIPIPRAZOLE | 02472244 | Marketed | |
| NRA-ARIPIPRAZOLE | 02472252 | Marketed | |
| NRA-ARIPIPRAZOLE | 02472260 | Marketed | |
| NRA-ARIPIPRAZOLE | 02472279 | Marketed | |
| NRA-ATORVASTATIN | 02476517 | Marketed | |
| NRA-ATORVASTATIN | 02476525 | Marketed | |
| NRA-ATORVASTATIN | 02476533 | Marketed | |
| NRA-ATORVASTATIN | 02476541 | Marketed | |
| NRA-AZITHROMYCIN | 02479680 | Marketed | |
| NRA-BETAHISTINE | 02544911 | Marketed | |
| NRA-BETAHISTINE | 02544938 | Marketed | |
| NRA-BETAHISTINE | 02544946 | Marketed | |
| NRA-BILASTINE | 02551934 | Marketed | |
| NRA-CANDESARTAN | 02527006 | Marketed | |
| NRA-CANDESARTAN | 02527014 | Marketed | |
| NRA-CANDESARTAN | 02527022 | Marketed | |
| NRA-CANDESARTAN | 02527030 | Marketed | |
| NRA-CANDESARTAN HCTZ | 02531240 | Marketed | |
| NRA-CANDESARTAN HCTZ | 02531259 | Marketed | |
| NRA-CANDESARTAN HCTZ | 02531267 | Marketed | |
| NRA-CELECOXIB | 02479737 | Marketed | |
| NRA-CELECOXIB | 02479745 | Marketed | |
| NRA-CETIRIZINE TABLETS | 02530236 | Marketed | |
| NRA-CIPROFLOXACIN | 02492008 | Marketed | |
| NRA-CITALOPRAM | 02477637 | Marketed | |
| NRA-CITALOPRAM | 02477645 | Marketed | |
| NRA-CITALOPRAM | 02477653 | Marketed | |
| NRA-CLINDAMYCIN | 02493748 | Marketed | |
| NRA-CLINDAMYCIN | 02493756 | Marketed | |
| NRA-CLOPIDOGREL | 02482037 | Marketed | |
| NRA-DAPAGLIFLOZIN | 02538334 | Marketed | |
| NRA-DAPAGLIFLOZIN | 02538342 | Marketed | |
| NRA-DOMPERIDONE | 02561905 | Marketed | |
| NRA-DONEPEZIL | 02535386 | Marketed | |
| NRA-DONEPEZIL | 02535394 | Marketed | |
| NRA-DOXYCYCLINE | 02558505 | Marketed | |
| NRA-DULOXETINE | 02482126 | Marketed | |
| NRA-DULOXETINE | 02482134 | Marketed | |
| NRA-DUTASTERIDE | 02490587 | Marketed | |
| NRA-ENALAPRIL | 02565285 | Marketed | |
| NRA-ENALAPRIL | 02565293 | Marketed | |
| NRA-ENALAPRIL | 02565307 | Marketed | |
| NRA-ENALAPRIL | 02565315 | Marketed | |
| NRA-ESCITALOPRAM | 02476851 | Marketed | |
| NRA-ESCITALOPRAM | 02476878 | Marketed | |
| NRA-EZETIMIBE TABLETS | 02536420 | Marketed | |
| NRA-FINASTERIDE | 02535637 | Marketed | |
| NRA-FLUCONAZOLE-150 | 02433702 | Marketed | |
| NRA-FLUOXETINE | 02503875 | Marketed | |
| NRA-FLUOXETINE | 02503883 | Marketed | |
| NRA-GABAPENTIN | 02550016 | Marketed | |
| NRA-GABAPENTIN | 02550024 | Marketed | |
| NRA-GABAPENTIN | 02550032 | Marketed | |
| NRA-HYDROXYCHLOROQUINE | 02511886 | Marketed | |
| NRA-LETROZOLE | 02520486 | Marketed | |
| NRA-LEVETIRACETAM | 02499193 | Marketed | |
| NRA-LEVETIRACETAM | 02499215 | Marketed | |
| NRA-LURASIDONE | 02522314 | Marketed | |
| NRA-LURASIDONE | 02522322 | Marketed | |
| NRA-LURASIDONE | 02522330 | Marketed | |
| NRA-LURASIDONE | 02522349 | Marketed | |
| NRA-METFORMIN | 02536439 | Marketed | |
| NRA-METFORMIN | 02536447 | Marketed | |
| NRA-MIRTAZAPINE | 02534924 | Marketed | |
| NRA-MIRTAZAPINE | 02534932 | Marketed | |
| NRA-MIRTAZAPINE | 02534940 | Marketed | |
| NRA-MONTELUKAST | 02489821 | Marketed | |
| NRA-OLANZAPINE | 02545586 | Marketed | |
| NRA-OLANZAPINE | 02545594 | Marketed | |
| NRA-OLANZAPINE | 02545608 | Marketed | |
| NRA-OLANZAPINE | 02545616 | Marketed | |
| NRA-OLANZAPINE | 02545624 | Marketed | |
| NRA-OLANZAPINE | 02545632 | Marketed | |
| NRA-OLANZAPINE ODT | 02536188 | Marketed | |
| NRA-OLANZAPINE ODT | 02536196 | Marketed | |
| NRA-OLANZAPINE ODT | 02536218 | Marketed | |
| NRA-OLANZAPINE ODT | 02536226 | Marketed | |
| NRA-OLMESARTAN | 02499258 | Marketed | |
| NRA-OLMESARTAN | 02499266 | Marketed | |
| NRA-OLMESARTAN HCTZ | 02508273 | Marketed | |
| NRA-OLMESARTAN HCTZ | 02508281 | Marketed | |
| NRA-OLMESARTAN HCTZ | 02508303 | Marketed | |
| NRA-ONDANSETRON | 02565366 | Marketed | |
| NRA-ONDANSETRON | 02565374 | Marketed | |
| NRA-PANTOPRAZOLE | 02471825 | Marketed | |
| NRA-PAROXETINE | 02479753 | Marketed | |
| NRA-PAROXETINE | 02479761 | Marketed | |
| NRA-PAROXETINE | 02479788 | Marketed | |
| NRA-PERINDOPRIL | 02489015 | Marketed | |
| NRA-PERINDOPRIL | 02489023 | Marketed | |
| NRA-PERINDOPRIL | 02489031 | Marketed | |
| NRA-PRAVASTATIN | 02535653 | Marketed | |
| NRA-PRAVASTATIN | 02535661 | Marketed | |
| NRA-PRAVASTATIN | 02535688 | Marketed | |
| NRA-PREGABALIN | 02479117 | Marketed | |
| NRA-PREGABALIN | 02479125 | Marketed | |
| NRA-PREGABALIN | 02479133 | Marketed | |
| NRA-PREGABALIN | 02479168 | Marketed | |
| NRA-PREGABALIN | 02479192 | Marketed | |
| NRA-PRUCALOPRIDE | 02550377 | Marketed | |
| NRA-PRUCALOPRIDE | 02550385 | Marketed | |
| NRA-QUETIAPINE | 02486237 | Marketed | |
| NRA-QUETIAPINE XR | 02510685 | Marketed | |
| NRA-QUETIAPINE XR | 02510707 | Marketed | |
| NRA-QUETIAPINE XR | 02510715 | Marketed | |
| NRA-RAMIPRIL | 02486172 | Marketed | |
| NRA-RAMIPRIL | 02486180 | Marketed | |
| NRA-RAMIPRIL | 02486199 | Marketed | |
| NRA-ROSUVASTATIN TABLETS | 02536595 | Marketed | |
| NRA-ROSUVASTATIN TABLETS | 02536609 | Marketed | |
| NRA-ROSUVASTATIN TABLETS | 02536625 | Marketed | |
| NRA-ROSUVASTATIN TABLETS | 02536633 | Marketed | |
| NRA-SERTRALINE | 02488434 | Marketed | |
| NRA-SERTRALINE | 02488442 | Marketed | |
| NRA-SERTRALINE | 02488450 | Marketed | |
| NRA-SILDENAFIL | 02476819 | Marketed | |
| NRA-TADALAFIL | 02520931 | Marketed | |
| NRA-TADALAFIL | 02520966 | Marketed | |
| NRA-TADALAFIL TABLETS | 02452480 | Marketed | |
| NRA-TADALAFIL TABLETS | 02452499 | Marketed | |
| NRA-TADALAFIL TABLETS | 02452502 | Marketed | |
| NRA-TELMISARTAN | 02503794 | Marketed | |
| NRA-TELMISARTAN | 02503808 | Marketed | |
| NRA-TELMISARTAN/HCTZ | 02504138 | Marketed | |
| NRA-TELMISARTAN/HCTZ | 02504146 | Marketed | |
| NRA-TOPIRAMATE | 02538458 | Marketed | |
| NRA-TOPIRAMATE | 02538466 | Marketed | |
| NRA-TOPIRAMATE | 02538474 | Marketed | |
| NRA-URSODIOL | 02544024 | Marketed | |
| NRA-URSODIOL | 02544032 | Marketed | |
| NRA-VARENICLINE | 02542951 | Marketed | |
| NRA-VARENICLINE | 02542978 | Marketed | |
| NRA-VARENICLINE | 02542986 | Marketed | |
| NRA-ZOLMITRIPTAN | 02489392 | Marketed | |
| NRA-ZOPICLONE | 02477378 | Marketed | |
| NRA-ZOPICLONE | 02477386 | Marketed | |
| MINOXIDIL 5% MEN / HOMMES | 02570300 | Approved | |
| NRA-ALENDRONATE | 02523094 | Approved | |
| NRA-ALENDRONATE | 02523108 | Approved | |
| NRA-AMOXICILLIN | 02561409 | Approved | |
| NRA-ANASTROZOLE | 02565358 | Approved | |
| NRA-APIXABAN | 02526050 | Dormant | |
| NRA-ATENOLOL | 02566230 | Approved | |
| NRA-ATENOLOL | 02566249 | Approved | |
| NRA-ATENOLOL | 02568837 | Approved | |
| NRA-AZITHROMYCIN | 02479699 | Approved | |
| NRA-BICALUTAMIDE | 02565919 | Approved | |
| NRA-CIPROFLOXACIN | 02491990 | Approved | |
| NRA-CIPROFLOXACIN | 02492016 | Approved | |
| NRA-CLOPIDOGREL | 02482045 | Approved | |
| NRA-DIENOGEST | 02566117 | Approved | |
| NRA-ESCITALOPRAM | 02489163 | Approved | |
| NRA-ESCITALOPRAM | 02489198 | Approved | |
| NRA-IMATINIB | 02571951 | Approved | |
| NRA-IMATINIB | 02571986 | Approved | |
| NRA-LEVETIRACETAM | 02499207 | Dormant | |
| NRA-LURASIDONE | 02522357 | Approved | |
| NRA-METFORMIN TABLETS | 02448084 | Approved | |
| NRA-METFORMIN TABLETS | 02448092 | Approved | |
| NRA-MONTELUKAST | 02548518 | Approved | |
| NRA-MONTELUKAST | 02548526 | Approved | |
| NRA-ONDANSETRON ODT | 02565129 | Approved | |
| NRA-ONDANSETRON ODT | 02565137 | Approved | |
| NRA-PANTOPRAZOLE | 02548097 | Approved | |
| NRA-PREGABALIN | 02479141 | Approved | |
| NRA-PREGABALIN | 02479176 | Approved | |
| NRA-PREGABALIN | 02479184 | Approved | |
| NRA-QUETIAPINE | 02486245 | Approved | |
| NRA-QUETIAPINE | 02486253 | Approved | |
| NRA-QUETIAPINE | 02486261 | Approved | |
| NRA-QUETIAPINE XR | 02510677 | Dormant | |
| NRA-QUETIAPINE XR | 02510693 | Dormant | |
| NRA-RAMIPRIL | 02486164 | Approved | |
| NRA-RAMIPRIL | 02486202 | Approved | |
| NRA-RISPERIDONE | 02565994 | Approved | |
| NRA-RISPERIDONE | 02566028 | Approved | |
| NRA-RISPERIDONE | 02566036 | Approved | |
| NRA-RISPERIDONE | 02566044 | Approved | |
| NRA-RISPERIDONE | 02566060 | Approved | |
| NRA-RISPERIDONE | 02566087 | Approved | |
| NRA-RIVAROXABAN | 02518651 | Approved | |
| NRA-RIVAROXABAN | 02518678 | Approved | |
| NRA-RIVAROXABAN | 02518686 | Approved | |
| NRA-RIVAROXABAN | 02518694 | Approved | |
| NRA-RIVAROXABAN TABLETS | 02566397 | Approved | |
| NRA-RIVAROXABAN TABLETS | 02566400 | Approved | |
| NRA-RIVAROXABAN TABLETS | 02566419 | Approved | |
| NRA-RIVAROXABAN TABLETS | 02566427 | Approved | |
| NRA-RIZATRIPTAN ODT | 02489376 | Approved | |
| NRA-RIZATRIPTAN ODT | 02489384 | Dormant | |
| NRA-SILDENAFIL | 02476797 | Approved | |
| NRA-SILDENAFIL | 02476800 | Approved | |
| NRA-SITAGLIPTIN | 02544423 | Approved | |
| NRA-SITAGLIPTIN | 02544431 | Approved | |
| NRA-SITAGLIPTIN | 02544458 | Approved | |
| NRA-SITAGLIPTIN TABLETS | 02566141 | Approved | |
| NRA-SITAGLIPTIN TABLETS | 02566168 | Approved | |
| NRA-SITAGLIPTIN TABLETS | 02566176 | Approved | |
| NRA-SITAGLIPTIN/METFORMIN | 02566281 | Approved | |
| NRA-SITAGLIPTIN/METFORMIN | 02566303 | Approved | |
| NRA-SITAGLIPTIN/METFORMIN | 02566311 | Approved | |
| NRA-TADALAFIL | 02520923 | Approved | |
| NRA-TADALAFIL | 02520958 | Approved | |
| NRA-TADALAFIL TABLETS | 02452472 | Dormant | |
| NRA-VENLAFAXINE XR | 02565544 | Approved | |
| NRA-VENLAFAXINE XR | 02565552 | Approved | |
| NRA-VENLAFAXINE XR | 02565560 | Approved | |
| NRA-ZOPICLONE | 02477351 | Dormant | |
| AMLODIPINE BESYLATE | 02503271 | Cancelled Pre Market | |
| AMLODIPINE BESYLATE | 02503298 | Cancelled Pre Market | |
| AMLODIPINE BESYLATE | 02503301 | Cancelled Pre Market | |
| AMLODIPINE TABLETS | 02444445 | Cancelled Post Market | |
| AMLODIPINE TABLETS | 02444453 | Cancelled Post Market | |
| AMLODIPINE TABLETS | 02444461 | Cancelled Post Market | |
| ATORVASTATIN | 02496607 | Cancelled Pre Market | |
| ATORVASTATIN | 02496615 | Cancelled Pre Market | |
| ATORVASTATIN | 02496623 | Cancelled Pre Market | |
| ATORVASTATIN | 02496631 | Cancelled Pre Market | |
| ESCITALOPRAM | 02489171 | Cancelled Post Market | |
| ESCITALOPRAM | 02489201 | Cancelled Post Market | |
| ESCITALOPRAM TABLETS | 02426331 | Cancelled Post Market | |
| ESCITALOPRAM TABLETS | 02426358 | Cancelled Post Market | |
| NRA-ASA 80 MG CROQUABLE | 02250675 | Cancelled Post Market | |
| NRA-CETIRIZINE | 02521806 | Cancelled Post Market | |
| NRA-DOCUSATE SODIUM | 02530538 | Cancelled Post Market | |
| NRA-EZETIMIBE | 02481669 | Cancelled Post Market | |
| NRA-FLECAINIDE | 02530066 | Cancelled Post Market | |
| NRA-FLECAINIDE | 02530074 | Cancelled Post Market | |
| NRA-LACOSAMIDE | 02499568 | Cancelled Post Market | |
| NRA-LACOSAMIDE | 02499576 | Cancelled Post Market | |
| NRA-LACOSAMIDE | 02499584 | Cancelled Post Market | |
| NRA-LACOSAMIDE | 02499592 | Cancelled Post Market | |
| NRA-OMEPRAZOLE | 02501880 | Cancelled Post Market | |
| NRA-ROSUVASTATIN | 02477483 | Cancelled Post Market | |
| NRA-ROSUVASTATIN | 02477491 | Cancelled Post Market | |
| NRA-ROSUVASTATIN | 02477505 | Cancelled Post Market | |
| NRA-ROSUVASTATIN | 02477513 | Cancelled Post Market | |
| NRA-TRAMADOL/ACET | 02469650 | Cancelled Post Market | |
| PANTOPRAZOLE | 02498715 | Cancelled Pre Market | |
| PANTOPRAZOLE | 02498723 | Cancelled Pre Market | |
| PANTOPRAZOLE TABLETS | 02425378 | Cancelled Post Market | |
| PRIVA-CELECOXIB | 02426366 | Cancelled Post Market | |
| PRIVA-CELECOXIB | 02426374 | Cancelled Post Market | |
| PRIVA-DULOXETINE | 02490420 | Cancelled Post Market | |
| PRIVA-DULOXETINE | 02490412 | Cancelled Post Market | |
| PRIVA-EZETIMIBE | 02425238 | Cancelled Post Market | |
| PRIVA-PERINDOPRIL ERBUMINE | 02483238 | Cancelled Post Market | |
| PRIVA-PERINDOPRIL ERBUMINE | 02483246 | Cancelled Post Market | |
| PRIVA-PERINDOPRIL ERBUMINE | 02483254 | Cancelled Post Market | |
| PRIVA-SERTRALINE | 02445352 | Cancelled Post Market | |
| PRIVA-SERTRALINE | 02445360 | Cancelled Post Market | |
| PRIVA-SERTRALINE | 02445387 | Cancelled Post Market | |
| PRIVA-SILDENAFIL | 02448785 | Cancelled Pre Market | |
| PRIVA-SILDENAFIL | 02448793 | Cancelled Pre Market | |
| PRIVA-SILDENAFIL | 02448807 | Cancelled Post Market | |
| ROSUVASTATIN | 02496054 | Cancelled Pre Market | |
| ROSUVASTATIN | 02496062 | Cancelled Pre Market | |
| ROSUVASTATIN | 02496070 | Cancelled Pre Market | |
| ROSUVASTATIN | 02496089 | Cancelled Pre Market | |
| ZOPICLONE TABLETS | 02425874 | Cancelled Post Market | |
| ZOPICLONE TABLETS | 02425882 | Cancelled Post Market | |
| ZOPICLONE TABLETS | 02492407 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| NRA-Phosphate Effervescent | 80127458 | Active | |
| Nora B12-1000 | 80121798 | Active | |
| Nora D-400 | 80120940 | Active | |
| Nora D-1000 | 80120939 | Active | |
| Nora Calcium | 80120791 | Active | |
| Nora Cal-D 400 | 80120785 | Active | |
| Nora Cal-D 400 | 80120783 | Active | |
| Nora Senna | 80120780 | Active | |
| Nora Sennosides | 80120779 | Active | |
| Nora Cal-D 1000 | 80120728 | Active |
Notices of Compliance
Newest first.
- NRA-DULOXETINEOctober 5, 2026 · NOC 38407 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-IMATINIBSeptember 28, 2026 · NOC 38369 · Abbreviated New Drug Submission (ANDS)
- NRA-RAMIPRILSeptember 21, 2026 · NOC 38327 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CITALOPRAMSeptember 15, 2026 · NOC 38286 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-GABAPENTINSeptember 4, 2026 · NOC 38239 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-RIVAROXABANSeptember 2, 2026 · NOC 38226 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-MONTELUKASTAugust 31, 2026 · NOC 38208 · Abbreviated New Drug Submission (ANDS)
- NRA-ZOPICLONEAugust 5, 2026 · NOC 38056 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MINOXIDIL 5% MEN / HOMMESJuly 28, 2026 · NOC 37992 · Abbreviated New Drug Submission (ANDS)
- NRA-METFORMIN TABLETSJuly 23, 2026 · NOC 37970 · Abbreviated New Drug Submission (ANDS)
- NRA-HYDROXYCHLOROQUINEJuly 22, 2026 · NOC 37960 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-TOPIRAMATEJune 30, 2026 · NOC 37806 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-TELMISARTANJune 29, 2026 · NOC 37793 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ATORVASTATINJune 19, 2026 · NOC 37742 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ATENOLOLJune 8, 2026 · NOC 37674 · New Drug Submission (NDS)
- NRA-MONTELUKASTMay 29, 2026 · NOC 37631 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-DULOXETINEMay 1, 2026 · NOC 37460 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CELECOXIBApril 29, 2026 · NOC 37424 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-RIVAROXABAN TABLETSMarch 4, 2026 · NOC 37032 · Abbreviated New Drug Submission (ANDS)
- NRA-SITAGLIPTIN/METFORMINMarch 3, 2026 · NOC 37023 · Abbreviated New Drug Submission (ANDS)
- NRA-SITAGLIPTIN TABLETSFebruary 25, 2026 · NOC 36961 · Abbreviated New Drug Submission (ANDS)
- NRA-ATENOLOLFebruary 25, 2026 · NOC 36975 · Abbreviated New Drug Submission (ANDS)
- NRA-RISPERIDONEFebruary 24, 2026 · NOC 36962 · Abbreviated New Drug Submission (ANDS)
- NRA-DIENOGESTFebruary 24, 2026 · NOC 36964 · Abbreviated New Drug Submission (ANDS)
- NRA-BICALUTAMIDEFebruary 20, 2026 · NOC 36945 · Abbreviated New Drug Submission (ANDS)
- NRA-VENLAFAXINE XRFebruary 4, 2026 · NOC 36839 · Abbreviated New Drug Submission (ANDS)
- NRA-ONDANSETRONFebruary 2, 2026 · NOC 36815 · Abbreviated New Drug Submission (ANDS)
- NRA-ZOLMITRIPTANFebruary 2, 2026 · NOC 36817 · Abbreviated New Drug Submission (ANDS)
- NRA-ANASTROZOLEJanuary 30, 2026 · NOC 36805 · Abbreviated New Drug Submission (ANDS)
- NRA-ENALAPRILJanuary 30, 2026 · NOC 36806 · Abbreviated New Drug Submission (ANDS)
- NRA-ONDANSETRON ODTJanuary 28, 2026 · NOC 36795 · Abbreviated New Drug Submission (ANDS)
- NRA-HYDROXYCHLOROQUINEJanuary 15, 2026 · NOC 36733 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-APIXABANJanuary 2, 2026 · NOC 36660 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-APIXABAN TABLETSDecember 29, 2025 · NOC 36646 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CANDESARTANDecember 29, 2025 · NOC 36648 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-DAPAGLIFLOZINDecember 23, 2025 · NOC 36613 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CETIRIZINE TABLETSNovember 27, 2025 · NOC 36440 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CITALOPRAMNovember 21, 2025 · NOC 36411 · Abbreviated New Drug Submission (ANDS)
- NRA-DONEPEZILNovember 10, 2025 · NOC 36342 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-QUETIAPINENovember 3, 2025 · NOC 36309 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-OLMESARTAN HCTZNovember 3, 2025 · NOC 36310 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CLOPIDOGRELOctober 23, 2025 · NOC 36235 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ROSUVASTATIN TABLETSOctober 23, 2025 · NOC 36237 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ZOPICLONEOctober 16, 2025 · NOC 36173 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-DOMPERIDONEOctober 10, 2025 · NOC 36141 · Abbreviated New Drug Submission (ANDS)
- NRA-AMOXICILLINSeptember 26, 2025 · NOC 36064 · Abbreviated New Drug Submission (ANDS)
- NRA-TELMISARTAN/HCTZJuly 25, 2025 · NOC 35747 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-PERINDOPRILJune 24, 2025 · NOC 35562 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-DOXYCYCLINEJune 18, 2025 · NOC 35540 · Abbreviated New Drug Submission (ANDS)
- NRA-DULOXETINEJune 12, 2025 · NOC 35514 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-TRAMADOL/ACETMay 22, 2025 · NOC 35395 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-PRAVASTATINMay 2, 2025 · NOC 35294 · Abbreviated New Drug Submission (ANDS)
- NRA-PREGABALINApril 11, 2025 · NOC 35163 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-METFORMIN TABLETSMarch 26, 2025 · NOC 35071 · Abbreviated New Drug Submission (ANDS)
- NRA-ZOLMITRIPTANMarch 13, 2025 · NOC 35008 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-FINASTERIDEMarch 7, 2025 · NOC 34987 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-EZETIMIBE TABLETSFebruary 28, 2025 · NOC 34925 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ROSUVASTATIN TABLETSFebruary 27, 2025 · NOC 34923 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-FLUCONAZOLE-150January 17, 2025 · NOC 34707 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CLINDAMYCINNovember 15, 2024 · NOC 34394 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-HYDROXYCHLOROQUINENovember 8, 2024 · NOC 34341 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-FLUOXETINEOctober 23, 2024 · NOC 34265 · Abbreviated New Drug Submission (ANDS)
- NRA-BILASTINEOctober 22, 2024 · NOC 34246 · Abbreviated New Drug Submission (ANDS)
- NRA-TELMISARTAN/HCTZOctober 16, 2024 · NOC 34199 · Abbreviated New Drug Submission (ANDS)
- NRA-TELMISARTANOctober 16, 2024 · NOC 34200 · Abbreviated New Drug Submission (ANDS)
- NRA-CANDESARTANOctober 4, 2024 · NOC 34137 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-LEVETIRACETAMSeptember 23, 2024 · NOC 34072 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-DAPAGLIFLOZINSeptember 18, 2024 · NOC 34042 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-OLMESARTANAugust 23, 2024 · NOC 33863 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ESCITALOPRAMAugust 12, 2024 · NOC 33800 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-GABAPENTINJuly 19, 2024 · NOC 33679 · Abbreviated New Drug Submission (ANDS)
- NRA-PREGABALINJuly 17, 2024 · NOC 33657 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ALENDRONATEJuly 15, 2024 · NOC 33639 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-LURASIDONEJuly 8, 2024 · NOC 33596 · Abbreviated New Drug Submission (ANDS)
- NRA-ZOLMITRIPTANJuly 5, 2024 · NOC 33566 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-RIZATRIPTAN ODTJuly 5, 2024 · NOC 33568 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-CITALOPRAMJuly 5, 2024 · NOC 33588 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-MONTELUKASTJune 10, 2024 · NOC 33419 · Abbreviated New Drug Submission (ANDS)
- NRA-CETIRIZINE TABLETSMay 30, 2024 · NOC 33344 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-PAROXETINEMay 27, 2024 · NOC 33301 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-PANTOPRAZOLEMay 27, 2024 · NOC 33307 · Abbreviated New Drug Submission (ANDS)
- NRA-ROSUVASTATINMay 24, 2024 · NOC 33293 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-LETROZOLEMay 1, 2024 · NOC 33149 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NIOPEGApril 17, 2024 · NOC 33095 · New Drug Submission (NDS)
- NRA-ROSUVASTATIN TABLETSApril 12, 2024 · NOC 33049 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-APIXABAN TABLETSApril 5, 2024 · NOC 33011 · Abbreviated New Drug Submission (ANDS)
- NRA-QUETIAPINEApril 2, 2024 · NOC 32998 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-ATORVASTATINMarch 22, 2024 · NOC 32945 · Abbreviated New Drug Submission (ANDS)
- NRA-OLANZAPINE ODTMarch 19, 2024 · NOC 32917 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-OLANZAPINEFebruary 22, 2024 · NOC 32752 · Abbreviated New Drug Submission (ANDS)
- NRA-TADALAFIL TABLETSFebruary 20, 2024 · NOC 32741 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-BETAHISTINEFebruary 1, 2024 · NOC 32631 · Abbreviated New Drug Submission (ANDS)
- NRA-SITAGLIPTINJanuary 10, 2024 · NOC 32496 · Abbreviated New Drug Submission (ANDS)
- NRA-DUTASTERIDEJanuary 2, 2024 · NOC 32445 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-URSODIOLDecember 20, 2023 · NOC 32388 · Abbreviated New Drug Submission (ANDS)
- NRA-ESCITALOPRAMDecember 7, 2023 · NOC 32308 · Abbreviated New Drug Submission (ANDS)
- NRA-AMLODIPINEDecember 5, 2023 · NOC 32291 · Abbreviated New Drug Submission (ANDS)
- NRA-RIVAROXABANDecember 1, 2023 · NOC 32230 · Supplement to an Abbreviated New Drug Submission (SANDS)
- NRA-RIVAROXABANDecember 1, 2023 · NOC 32235 · Abbreviated New Drug Submission (ANDS)
- NRA-VARENICLINENovember 8, 2023 · NOC 32048 · Abbreviated New Drug Submission (ANDS)
The latest 100 of 201.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tabletsJuly 8, 2025 · Drugs · Product safety · Type I
- NRA-Amlodipine 5 mg tablets: One lot recalled as some bottles may contain the wrong drugJuly 7, 2025 · Drugs · Product safety
- NRA-Quetiapine XR: Some lots exceed the intake limit of N-nitroso-desalkyl-quetiapine (NDAQ)April 11, 2025 · Drugs · Product quality · Type II